3. Introduction
Trigeminal neuralgia (TN) is a painful
condition that is associated with sudden,
lancinating, unilateral pain attacks in the
distribution of the trigeminal nerve
branches.
The attacks last from a few seconds up
to 2 min and are often associated with
typical triggers (e.g. brushing teeth,
talking, eating).
There is generally no pain between
Olesen J. International classification of headache disorders. The Lancet Neurology. 2018 May 1;17(5):396-7.
4. Classification of TN
Primary
• Compression by blood vessel
Secondary
• Tumor
• Demyelination (multiple
sclerosis)
Cruccu G, Finnerup NB, Jensen TS, Scholz J, Sindou M, Svensson P, Treede RD, Zakrzewska JM, Nurmikko T. Trigeminal neuralgia: new classification and
diagnostic grading for practice and research. Neurology. 2016 Jul 12;87(2):220-8.
5. Epidemiology
The annual incidence of TN is
reported as 4.7–28.9 per 100 000
person years
The age of onset is 53–60 yr
1.5–1.9 times more common in
women
Moore D, Chong MS, Shetty A, Zakrzewska JM. A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia.
British journal of anaesthesia. 2019 Aug 1;123(2):e385-96.
6. Clinical Manifestation
Moderate to severe episodes of pain with
associated functional, occupational, and
emotional impairment and disability
Most treatment options in TN are
symptomatic and aim to reduce the
severity and frequency of attacks in the
future
There is limited evidence on
interventions that offer rescue analgesia
in the acute phase of an exacerbation or
attack
Zakrzewska JM, Wu J, Mon-Williams M, Phillips N, Pavitt SH. Evaluating the impact of trigeminal neuralgia. Pain. 2017 Jun 1;158(6):1166-74.
7. Acute Exacerbation
Management
Moore D, Chong MS, Shetty A, Zakrzewska JM. A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia.
British journal of anaesthesia. 2019 Aug 1;123(2):e385-96.
Most of the interventions give
less than 24 h of pain relief,
so a more definitive care plan
needs to be put in place
8. Summary
Trigeminal neuralgia is associated with
periods of moderate to severe flare-up
that can have a detrimental impact on an
individual's personal and professional life
Many current treatment strategies are
aimed at long-term symptom control and
fail to give acute pain control (within 24
h)
Weak evidence exists to support the use
of lidocaine, sumatriptan,
phenytoin/fosphenytoin, botulinum toxin,
and MgSO4 as acute rescue analgesics
Future studies needed